AZN — AstraZeneca Share News

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Market Cap
£198.21bn
Enterprise Value
£217.54bn
Revenue
$54.07bn

REG - AstraZeneca PLC - Holding(s) in Company
22/07/2020 15:00Announcement
REG - AstraZeneca PLC - Holding(s) in Company
21/07/2020 15:00Announcement
REG - AstraZeneca PLC - Holding(s) in Company
21/07/2020 15:00Announcement
REG - AstraZeneca PLC - COVID-19 vaccine Phase I/II showed immune response
20/07/2020 14:45Announcement
REG - AstraZeneca PLC - Director Declaration
16/07/2020 07:00Announcement
REG - Jupiter Asset Mgmnt - Portfolio Update
15/07/2020 17:35Announcement
REG - AstraZeneca PLC - Brilinta granted US FDA Priority Review for stroke
09/07/2020 07:01Announcement
REG - AstraZeneca PLC - Lynparza approved in the EU for pancreatic cancer
08/07/2020 07:01Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/07/2020 15:00Announcement
REG - AstraZeneca PLC - Director/PDMR Shareholding
30/06/2020 15:00Announcement
REG - AstraZeneca PLC - Selumetinib granted Japan orphan drug designation
30/06/2020 07:01Announcement
REG - AstraZeneca PLC - Holding(s) in Company
17/06/2020 15:05Announcement
REG - AstraZeneca PLC - Holding(s) in Company
17/06/2020 15:00Announcement
REG - AstraZeneca PLC - Agreement to Supply Europe with COVID-19 Vaccine
15/06/2020 07:01Announcement
REG - AstraZeneca PLC - EMTN Programme Routine Technical Update
11/06/2020 07:01Announcement
REG - AstraZeneca PLC - Total Voting Rights
01/06/2020 15:00Announcement
REG - AstraZeneca PLC - Block listing Interim Review
01/06/2020 15:00Announcement
REG - AstraZeneca PLC - Brilinta obtains additional US approval
01/06/2020 07:06Announcement
REG - AstraZeneca PLC - Lynparza EU CHMP opinion in pancreatic cancer
01/06/2020 07:05Announcement
REG - AstraZeneca PLC - Second Price Monitoring Extn
29/05/2020 16:45Announcement